Exane Derivatives’s NatWest NWG Stock Holding History

Exane Derivatives’s Portfolio NWG Stock Details NWG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-143	Closed	-$9.24K	–	630
2016 Q4	$9.24K	Buy	+143	New	+$769	﹤0.01%	400

Other funds holding NWG

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Exane Derivatives's NWG Position: Q3 2016 in Review

Exane Derivatives sold out of NatWest (NWG) in Q3 2016, closing a stake of 3,714 shares — an estimated $18.8K sold.

Exane Derivatives first reported a position in NWG in Q4 2014 and held it in 7 quarters. The position peaked at $493K in Q1 2015. 100 funds tracked by Wall St. Rank hold NWG as of Q3 2016.

Exane Derivatives reported no remaining NatWest position as of Q3 2016 after selling out during the quarter.
Exane Derivatives sold 3,714 NatWest shares in Q3 2016, an estimated $18.8K.
Exane Derivatives first reported a position in NatWest in Q4 2014 and held it in 7 quarters.
Exane Derivatives's NatWest position peaked at $493K in Q1 2015.
100 funds tracked by Wall St. Rank held NatWest as of Q3 2016.

Based on Exane Derivatives's 13F filing for Q3 2016, filed 26 Oct 2016.